A Prospective Observational Cohort Study on Dynamic CD8+ T-cell Profiling and Multi-omics Biomarkers for Predicting Conversion Therapy Response in Unresectable Hepatocellular Carcinoma
NCT07117279
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
120
Enrollment
OTHER
Sponsor class
Conditions
HCC - Hepatocellular Carcinoma
Sponsor
Tongji Hospital